Vir Biotechnology | 10-Q: Quarterly report
May 4 04:23
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 3 04:15
Vir Biotechnology | ARS: Annual Report to Security Holders
Apr 19 20:43
Vir Biotechnology | DEFA14A: Others
Apr 19 20:38
Vir Biotechnology | DEF 14A: Definitive information statements
Apr 19 20:33
Vir Biotechnology | 8-K: Current report
Apr 18 20:46
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer De Backer Marianne
Apr 5 04:19
Vir Biotechnology | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 5 03:36
Vir Biotechnology | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 4 04:18
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer HANLY ANN M.
Apr 3 09:01
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Lee Sung
Mar 29 00:24
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer HANLY ANN M.
Feb 27 08:37
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer De Backer Marianne
Feb 27 08:37
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Lee Sung
Feb 27 08:37
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Pang Phillip
Feb 27 08:37
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Feb 27 08:32
Vir Biotechnology | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 27 05:36
Vir Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 27 05:31
Vir Biotechnology | 10-K: Annual report
Feb 27 05:13
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 23 05:24
No Data
No Data